PreveCeutical Medical Overcomes Trade Hurdle, Advances Research
Company Announcements

PreveCeutical Medical Overcomes Trade Hurdle, Advances Research

Story Highlights

PreveCeutical Medical (TSE:PREV) has released an update.

PreveCeutical Medical Inc. has successfully finalized its interim financial filings, leading to the revocation of the Management Cease Trade Order by the British Columbia Securities Commission. The company, which focuses on preventive and curative health solutions, is advancing in its research programs with several provisional patent applications filed.

For further insights into TSE:PREV stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskPreveCeutical Boosts Marketing with OTB Partnership
TipRanks Canadian Auto-Generated NewsdeskPreveCeutical Nears Compliance, Foresees Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App